The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

lanova.com

Founded Year

2019

Stage

Series A | Alive

Total Raised

$87M

Valuation

$0000 

Last Raised

$87M | 1 yr ago

About LaNova Medicines

Lixin Pharmaceutical is a pharmaceutical firm based in China.

LaNova Medicines Headquarter Location

3rd Floor, Building 1, 400 Fangchun Road China (Shanghai) Pilot Free Trade Zone

Shanghai, Shanghai,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

LaNova Medicines Patents

LaNova Medicines has filed 4 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Transcription factors
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/16/2021

8/24/2021

Transcription factors, Monoclonal antibodies, Immunology, Clusters of differentiation, Immune system

Grant

Application Date

2/16/2021

Grant Date

8/24/2021

Title

Related Topics

Transcription factors, Monoclonal antibodies, Immunology, Clusters of differentiation, Immune system

Status

Grant

Latest LaNova Medicines News

Asychem Partners with LaNova Medicines

Sep 17, 2021

Will provide one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.

LaNova Medicines Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

LaNova Medicines Rank

  • When was LaNova Medicines founded?

    LaNova Medicines was founded in 2019.

  • Where is LaNova Medicines's headquarters?

    LaNova Medicines's headquarters is located at 3rd Floor, Building 1, 400 Fangchun Road, Shanghai.

  • What is LaNova Medicines's latest funding round?

    LaNova Medicines's latest funding round is Series A.

  • How much did LaNova Medicines raise?

    LaNova Medicines raised a total of $87M.

  • Who are the investors of LaNova Medicines?

    Investors of LaNova Medicines include Qiming Venture Partners, YINGKE PE, Nuoyao Biotechnology, TF Capital, Tigermed and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.